Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
6.66
-0.38 (-5.40%)
At close: Mar 27, 2026, 4:00 PM EDT
6.57
-0.09 (-1.35%)
After-hours: Mar 27, 2026, 7:50 PM EDT
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $41.21 million as of March 27, 2026. Its market cap has decreased by -34.44% in one year.
Market Cap
41.21M
Enterprise Value
-31.38M
1-Year Change
-34.44%
Ranking
Category
Stock Price
$6.66
Market Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $41.21M, a decrease of -92.55%. That is a compound annual growth rate of -37.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 41.21M | -28.14% |
| Dec 31, 2025 | 57.35M | -61.21% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kezar Life Sciences | 45.40M |
| Lisata Therapeutics | 45.34M |
| Estrella Immunopharma | 44.80M |
| Rallybio | 43.48M |
| Telomir Pharmaceuticals | 42.98M |
| Atossa Therapeutics | 40.65M |
| Lite Strategy | 40.00M |
| NovaBay Pharmaceuticals | 39.94M |